G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial

被引:0
|
作者
Link, H
Wandt, H
SchonrockNabulsi, P
Ehninger, G
Franke, A
Gackle, R
Geer, T
Gramatzki, M
Linkesch, W
Lutz, D
Niederwieser, D
Nikiforakis, E
Ohl, S
Otremba, B
Pittermann, E
Schmidt, H
Tischler, J
Weiss, J
Wilhelm, M
Deutschmann, S
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:841 / 841
页数:1
相关论文
共 50 条
  • [41] Remission of familial acute myelogenic leukemia by G-CSF
    Katevas, P
    StefanoudakiSofianatou, K
    Fisfis, M
    Drossou, M
    Kapsimali, V
    Psarra, A
    Spiropoulou, M
    Economidou, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 836 - 836
  • [42] Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3
    Aulitzky, WE
    Neubauer, A
    Kolbe, K
    Schneller, F
    Busemann, C
    Schleiermacher, E
    Peschel, C
    Siegert, W
    Huber, C
    Huhn, D
    BONE MARROW TRANSPLANTATION, 1996, 17 : S67 - S69
  • [43] Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor
    Weng, Ping
    Yang, Shu
    Xu, Shujuan
    Zhang, Shuxia
    Wu, Yong
    Chen, Yuanzhong
    HEMATOLOGY, 2023, 28 (01)
  • [44] Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
    Freedman, MH
    Bonilla, MA
    Fier, C
    Bolyard, AA
    Scarlata, D
    Boxer, LA
    Brown, S
    Cham, B
    Kannourakis, G
    Kinsey, SE
    Mori, PG
    Cottle, T
    Welte, K
    Dale, DC
    BLOOD, 2000, 96 (02) : 429 - 436
  • [45] Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
    Milligan, Donald W.
    Wheatley, Keith
    Littlewood, Timothy
    Craig, Jenny I. O.
    Burnett, Alan K.
    BLOOD, 2006, 107 (12) : 4614 - 4622
  • [46] Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia
    Boque, C
    Petit, J
    Sarra, J
    Cancelas, JA
    Munoz, J
    Espanol, JI
    delaBanda, E
    Aventin, A
    Berlanga, J
    Ferra, C
    Amill, B
    Torrico, C
    Azqueta, C
    Llucia, M
    Garcia, J
    Granena, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 879 - 884
  • [47] Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial
    M Karthaus
    C Rosenthal
    G Huebner
    H Paul
    C Elser
    B Hertenstein
    J Krauter
    T Scharmann
    RG Geissler
    G Heil
    A Ganser
    Bone Marrow Transplantation, 1998, 22 : 781 - 785
  • [48] Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial
    Karthaus, M
    Rosenthal, C
    Huebner, G
    Paul, H
    Elser, C
    Hertenstein, B
    Krauter, J
    Scharmann, T
    Geissler, RG
    Heil, G
    Ganser, A
    BONE MARROW TRANSPLANTATION, 1998, 22 (08) : 781 - 785
  • [49] GM-CSF during as well as after induction chemotherapy (CT) in elderly patients with acute myeloid leukemia (AML). The EORTC-HOVON phase III trial (AML 11).
    Lowenberg, B
    Suciu, S
    Zittoun, R
    Ossenkoppele, G
    Boogaerts, MA
    Wijermans, P
    Vellenga, E
    Berneman, Z
    Deffer, AW
    Sonneveld, P
    Stryckmans, P
    Solbu, G
    Dardenne, M
    deWitte, T
    Archimbaud, E
    BLOOD, 1995, 86 (10) : 1719 - 1719
  • [50] Acute arteritis after G-CSF administration
    Kinjo, Yasuyuki
    Kurita, Tomoko
    Ueda, Taeko
    Kagami, Seiji
    Matsuura, Yusuke
    Yoshino, Kiyoshi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2019, 8 (02) : 77 - 80